Fulgent Genetics Inc (FLGT) — Cash Flow-to-Debt Ratio
Fulgent Genetics Inc (FLGT) has a Cash Flow-to-Debt Ratio of 0.06x as of March 2026, meaning its operating cash flow of $7.10 Million could theoretically repay 0% of its total liabilities ($112.22 Million) in one year. Explore FLGT long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Fulgent Genetics Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Fulgent Genetics Inc across 12 annual periods. Also explore Fulgent Genetics Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Fulgent Genetics Inc (2014–2025)
Year-by-year debt coverage analysis for Fulgent Genetics Inc. For market capitalisation and broader financial context, see FLGT market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.95x | $-101.64 Million | $106.81 Million | ▼ -510.3% |
| 2024 | 0.23x | $21.06 Million | $90.81 Million | ▼ -12.4% |
| 2023 | 0.26x | $27.00 Million | $102.04 Million | ▼ -87.9% |
| 2022 | 2.18x | $253.52 Million | $116.18 Million | ▼ -54.3% |
| 2021 | 4.77x | $538.58 Million | $112.84 Million | ▲ +344.9% |
| 2020 | 1.07x | $140.63 Million | $131.07 Million | ▲ +16.3% |
| 2019 | 0.92x | $5.52 Million | $5.98 Million | ▲ +475.2% |
| 2018 | -0.25x | $-675.00K | $2.75 Million | ▼ -154.0% |
| 2017 | 0.46x | $1.33 Million | $2.92 Million | ▼ -63.2% |
| 2016 | 1.24x | $4.41 Million | $3.56 Million | ▲ +187.6% |
| 2015 | -1.41x | $-969.00K | $686.00K | ▲ +86.0% |
| 2014 | -10.08x | $-4.40 Million | $436.00K | — |